Elanc Animl Hlth Rg
ELAN
USD
STOCK MARKET:
NYX
Closed
 
...
Large gap with delayed quotes
Last quote
10/24/2025 - 22:15:00
Bid
10/24/2025 - 21:59:59
Bid
Volume
Ask
10/24/2025 - 21:59:59
Ask
Volume
22.05
+0.28 ( +1.29% )
22.05
22,800
22.06
1,800
More information
Analysis by TheScreener
24.10.2025
Evaluation Neutral  
Interest Weak  
Sensibility Middle  
Analysis date: 24.10.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 22.04.2025.
Interest
  Weak
Two stars since 10.10.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 10.10.2025 at a price of 19.76.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 08.08.2025.
4wk Rel Perf
  16.91%
 
The four-week dividend-adjusted overperformance versus SP500 is 16.91%.
Sensibility
  Middle
Moderate, no change over 1 year.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.80%.
Mkt Cap in $bn
  10.82
With a market capitalization >$8bn, ELANCO ANIMAL HEALTH is considered a large-cap stock.
G/PE Ratio
  0.81
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  18.97
The estimated PE is for the year 2027.
LT Growth
  15.41%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  132
For 1% of index variation, the stock varies on average by 1.32%.
Correlation
  0.52
52.04% of stock movements are explained by index variations.
Value at Risk
  5.29
The value at risk is estimated at USD 5.29. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  08.01.2019